Immunohistochemical expression of TRPS1 in mammary Paget disease, extramammary Paget disease, and their close histopathologic mimics
- 1 March 2023
- journal article
- research article
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 50 (5) , 434-440
Abstract
Background: Trichorhinophalangeal syndrome type 1 (TPRS1) expression has been found to be highly sensitive and specific for breast carcinomas. The frequency of TRPS1 expression in cutaneous neoplasms such as mammary Paget disease (MPD) and extramammary PD (EMPD) is currently unknown. We assessed the utility of TRPS1 immunohistochemistry (IHC) in the evaluation of MPD, EMPD, and their histopathologic mimics, squamous cell carcinoma in situ (SCCIS) and melanoma in situ (MIS).Methods: Twenty‐four MPDs, 19 EMPDs, 13 SCCISs, and 9 MISs were subjected to immunohistochemical analysis using anti‐TRPS1 antibody. The intensity (none, 0; weak, 1+; moderate, 2+; strong, 3+) and proportion (75%, diffuse) of TRPS1 expression were recorded. Relevant clinical data were documented.Results: TPRS1 expression was present in 100% (24/24) of MPDs, with 88% (21/24) of MPDs exhibiting strong, diffuse immunoreactivity. Sixty‐eight percent (13/19) of EMPDs showed TRPS1 expression. Intriguingly, EMPDs lacking TRPS1 expression were consistently of perianal origin. TRPS1 expression was seen in 92% (12/13) of SCCISs but was absent in all MISs.Conclusions: TRPS1 may be useful to distinguish MPDs/EMPDs from MISs, but its utility is limited in distinguishing them from other pagetoid intraepidermal neoplasms such as SCCISs.Keywords
Funding Information
- University of Texas MD Anderson Cancer Center
This publication has 9 references indexed in Scilit:
- Trichorhinophalangeal Syndrome Type 1–Positive Cells in Breast Dermal Granulation Tissues and Scars: A Potential Diagnostic PitfallThe American Journal of Dermatopathology, 2022
- Evidence-Based Clinical Practice Guidelines for Extramammary Paget DiseaseJAMA Oncology, 2022
- Expression of TRPS1 in phyllodes tumor and sarcoma of the breastHuman Pathology, 2022
- Not All Cases of Mammary Paget’s Disease are Cytokeratin-7 Positive: A Challenging Diagnosis!International Journal of Surgical Pathology, 2021
- High Risk of Proximal and Local Neoplasms in 2206 Patients With Anogenital Extramammary Paget’s DiseaseDiseases of the Colon & Rectum, 2019
- Evidence-Based Screening Recommendations for Occult Cancers in the Setting of Newly Diagnosed Extramammary Paget DiseaseMayo Clinic Proceedings, 2018
- Cytokeratin 7-negative mammary Paget's disease: A diagnostic pitfallPathology - Research and Practice, 2016
- Diagnostic Utility of p63 Expression in the Differential Diagnosis of Pagetoid Squamous Cell Carcinoma In Situ and Extramammary Paget DiseaseThe American Journal of Dermatopathology, 2014
- Expression of CK7, Cam 5.2 and Ber‐Ep4 in cutaneous squamous cell carcinomaJournal of Cutaneous Pathology, 2013